Reynoso Jamie L.

Reynoso Jamie L., CEO of Medicare Advantage at Clover Health (CLOV), has demonstrated a consistent pattern of selling activity in the company’s stock, with no recorded purchases across 27 transactions totaling $1.54 million in sales. The trades, spanning from July 2025 through March 2026, show a mix of discretionary sales (code "S") and transactions tied to tax withholding or vesting events (code "F"). Notably, the largest single sale occurred on October 31, 2025, when Reynoso disposed of shares worth $359,767.01, followed by another $104,180.89 the same day—both classified as withholding-related transactions. Other significant sales include a $108,778.30 transaction on November 4, 2025, and a $200,009.60 withholding-related trade on October 15, 2025. Recent activity reinforces this sell-side trend, with 11 disposals since October 2025, including multiple mid-sized transactions in March 2026. For example, Reynoso sold $11,141.03 worth of shares on March 18, 2026, following a $12,250.26 withholding-related transaction three days prior. The pattern suggests ongoing monetization of equity, likely tied to compensation-related vesting schedules rather than open-market sales. All transactions involve CLOV, indicating concentrated exposure to the company. The absence of buy orders and the recurring nature of the sales—particularly around mid-month and quarter-end dates—point to structured divestment rather than discretionary market timing.